Dutch Botanicals LLC Stipulation Agreement Order

This document is a Stipulation Agreement Order issued by a US federal agency, likely the FDA, against Dutch Botanicals LLC, dated January 28, 2026. The order signifies a formal agreement to resolve alleged violations, which typically involve non-compliance with regulations concerning product manufacturing, labeling, or marketing claims. The specific nature of the violations and the terms of the agreement would be detailed within the full document, but such orders often require corrective actions and may include admissions of fact or liability.

For regulated entities, this order serves as a critical reminder of the importance of adhering to federal regulations. Dutch Botanicals LLC is bound by the terms of this agreement, which may include specific compliance deadlines, reporting requirements, and potential penalties for future non-compliance. Other food manufacturers and dietary supplement companies should review their own practices to ensure alignment with FDA regulations, particularly concerning product safety, quality, and truthful marketing, to avoid similar enforcement actions.